European Union:
Conglomerate Effects: An EU Resurgence?
21 August 2019
Shearman & Sterling LLP
To print this article, all you need is to be registered or login on Mondaq.com.
The European Commission (EC) is increasingly invoking
conglomerate theories of harm in its merger reviews. The complexity
of these theories is resulting in more in-depth Phase 2 reviews and
behavioral access commitments are relatively common for
conglomerate mergers in the high-tech space.
Read this chapter in Shearman &
Sterling's 2019 Antitrust Annual Report, "Conglomerate
Effects: An EU Resurgence?"
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Antitrust/Competition Law from European Union
US Antitrust Agencies Release Final Revised Merger Guidelines
Goodwin Procter LLP
On December 18, 2023, the Federal Trade Commission and the Antitrust Division of the Department of Justice released the final version of revised Merger Guidelines, a set of principles Agencies use in their review of mergers and acquisitions.
